DAWN
Day One Biopharmaceuticals, IncHealthcare$21.45
▼ Bearish
Mkt Cap: $2.22B|Float: 68.7M|SI: 11.8%|DTC: 1.1
Data as of market close Apr 2, 2026
IV Rank
50
IV Pctl
44%
HV 20d
17947.0%
52W Range
$6-$21
ATR(14)
$0.06
Exp. Move
±8.7%
P/C Ratio
1.20
Earnings
May 5
GEX Negative
DEX Long
Net Call Premium
IV Moderate
Max Pain Below
Exp. Move Wide
High Put/Call
DAWN Key Options Data
- IV Rank
- 49.8%
- Total GEX
- $-0.00B
- Total DEX
- $2.0M
- Max Pain
- $13.00
- Expected Move
- ±8.7%
- Put/Call OI
- 1.20
- Net Premium
- $0.2M
- Spot Price
- $21.45
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-17 | 15 | ±$1.88 | ±8.7% | $19.58 | $23.33 |
| 2026-05-15 | 43 | ±$0.55 | ±2.6% | $20.90 | $22.00 |
| 2026-07-17 | 106 | ±$1.05 | ±4.9% | $20.40 | $22.50 |
| 2026-10-16 | 197 | ±$0.58 | ±2.7% | $20.88 | $22.03 |
| 2027-01-15 | 288 | ±$0.05 | ±0.2% | $21.40 | $21.50 |
Explore DAWN options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.